Evidence-Based Reviews

Cognitive-behavioral therapy for insomnia: A review of 8 studies

Author and Disclosure Information

 

References

Outcomes

  • Both CBT-I and SRT outperformed SHE on the ISI and for most of the sleep parameters on sleep diaries immediately after treatment completion and at 6 months after treatment.
  • Total sleep time was 40 to 43 minutes longer in the CBT-I group than in the SRT and SHE groups at 6-month follow-up.
  • Remission rates (sleep onset latency ≤30 minutes, wake time after sleep onset ≤30 minutes, sleep efficiency ≥85%) were significantly higher in CBT-I group (CBT-I > SRT > SHE).

Conclusion

  • Sleep hygiene education as a standalone treatment is not useful for treating chronic insomnia.
  • Both CBT-I and SRT are efficacious for menopause-related insomnia.
  • CBT-I may be a better option than SRT because it produces higher remission rates and better long-term outcomes.

6. Kalmbach DA, Cheng P, Arnedt JT, et al. Improving daytime functioning, work performance, and quality of life in postmenopausal women with insomnia: comparing cognitive behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. J Clin Sleep Med. 2019;15(7):999-1010.

CBT-I has shown efficacy in the treatment of insomnia in postmenopausal women. In this study, Kalmbach et al14 compared 3 nonpharmacologic modalities—CBT-I, SRT, and SHE—for the treatment of menopause-related insomnia and daytime impairment.

Study design

  • In this RCT, 150 participants with new peri- and post-menopausal onset or exacerbation of insomnia were randomized to 1 of 3 groups: SHE, SRT, or CBT-I.
  • Participants were assessed at baseline, after treatment completion, and at 6-month follow-up using the ISI, sleep diaries, Fatigue Severity Scale, Epworth Sleepiness Scale, Work Productivity and Activity Impairment Questionnaire, and 36-item Medical Outcomes Study Short Form Health Survey.

Continue to: Outcomes

Pages

Recommended Reading

Sleep quality may affect COPD risk in African American smokers
MDedge Psychiatry
COVID-19: Delirium first, depression, anxiety, insomnia later?
MDedge Psychiatry
Less REM sleep tied to higher mortality
MDedge Psychiatry
FDA approves low-sodium treatment option for narcolepsy
MDedge Psychiatry
Pandemic-related stress causing health issues in many Americans
MDedge Psychiatry
Patients with COPD plus sleep problems should be screened for mood disorders
MDedge Psychiatry
‘Long sleep’ or apnea in middle age double risk for Alzheimer’s disease
MDedge Psychiatry
Sleep problems in young children linked to lower QOL in later years
MDedge Psychiatry
Clinical pearls for administering cognitive exams during the pandemic
MDedge Psychiatry
Alzheimer’s disease may affect sleep patterns
MDedge Psychiatry